logo

Personal-use Self-monitoring Blood Glucose Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Market is Segmented by Component (Glucometer Device, Blood Glucose Test Strips, Lancets), and Geography.

Home Industry Reports Healthcare Personal-use Self-monitoring Blood Glucose Market - Growth, Trends, COVID-19 Imp ...

Market Snapshot

personal use glucometer device market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: North America
Largest Market: North America
CAGR: 0 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

  • The personal-use self-monitoring blood glucose (SMBG) market has grown in recent years, due to an increased awareness among diabetes patients. New technological innovations in glucometers and their ease of usage, have made diabetes and pre-diabetes patients more conscientious in monitoring and controlling their blood glucose levels.    
  • Currently, the home user market holds the highest market share and is expected to increase. As a result of this, the demand for home usage of self-monitoring blood glucose devices is not only high among diabetes patients, but also among other people who want to know their health situation regularly.
  • One of the fastest-growing chronic diseases in the world is diabetes. Diabetes is a disease that occurs when the glucose levels of the body increase to more than the normal level, and the body is unable to produce insulin. Glucometers are used to monitor glucose levels. The type 1 diabetes population around the world is rising, while witnessing a CAGR of 2.13%. As the diabetic population increases, the self-monitoring blood glucose devices market is also bound to increase.
  • Other factors, such as technological innovations, the convenience of conventional glucose monitoring over regular monitoring, and early detection of hypo- and hyperglycemic diabetes are the primary drivers for market growth.

Scope of the Report

In 2018, the global home usage segment of the self-monitoring blood glucose devices market was estimated to value around USD 4,399.3 million. The market is expected to register a CAGR of about 16.4 %, during the forecast period (2019-2024). The market is segmented by component (glucometer device, blood glucose test strips, lancets), and geography.

By Usage
Personal-use Self-monitoring Blood Glucose Devices (Value and Volume, 2012 - 2024)
By Component
Glucometer Devices
Test Strips
Lancets
Geography
North America
United States (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Canada (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Rest of North America (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Europe
France (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Germany (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Italy (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Spain (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
United Kingdom (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Russia (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Rest of Europe (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Latin America
Mexico (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Brazil (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Rest of Latin America (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Asia-Pacific
Japan (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
South Korea (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
China (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
By End User (Hospital and Home)
India (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
By End User (Hospital and Home)
Australia (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Vietnam (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Malaysia (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Indonesia (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Philippines (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Thailand (Value and Volume, 2012 - 2024)
Rest of Asia-Pacific (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Middle East & Africa
Saudi Arabia (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
By End User (Hospital and Home)
Iran (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Egypt (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Oman (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
South Africa (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Rest of Middle & Africa (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)

Report scope can be customized per your requirements. Click here.

Key Market Trends

Blood Glucose Test Strips Hold the Highest Market Share

  • Blood glucose test strips have the highest market share, with 77%, in the global personal usage market of self-monitoring blood glucose (SMBG) devices. As the blood glucose test strips are only for one-time use, the expenditure spent on test strips is high because of the need for their continuous replacement.
  • The glucometer is considered to be a one-time purchase. Test strips, on the other hand, are supposed to be a continuous investment, as a test strip needs to be disposed of after one use. Thus, this presents a considerable cost impact to the consumers.  
  • Overall, the global demand for blood glucose test strips is projected to witness significant growth over the forecast period. The growth of the market studied is expected to be spurred by the rising global diabetic population.
  • The growth in market volumes and share of the test strip segment is expected to be better than that of glucometers, because of the difference in use-case frequency. While an average glucose meter lasts anywhere between six months and three years, presenting a one-time cost, during the same time frame, the corresponding use of multiple (in the range of thousands) test strips may occur, causing a recurrent cost impact.
personal use glucometer device market

North America has the Highest Market Share, with a 21.63% CAGR

  • The North America test strips market has the highest market share, with a revenue of USD 2 billion, followed by Europe and Asia-Pacific.
  • The United States alone has around 80% share in the North America blood glucose test strips market.
  • The price policies and favorable reimbursement policies in North America are driving the growth of the North America personal-use glucometer device market.  
personal use glucometer device market

Competitive Landscape

  • The global personal-use glucometer market is highly consolidated, with a few major manufacturers having their presence in major regions of the global market, while the remaining manufacturers are limited to other local or region-specific manufacturers. 
  • The innovations in self-monitoring blood glucose devices are increasing and are under development. 
  • ColorSure® Dynamic Range Indicator (ColorSure® PLUS) is an expansion of ColorSure® technology from the OneTouch® brand. ColorSure® PLUS technology is designed to help patients understand when glucose results are nearing highs or lows.
personal use glucometer device market

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Usage

      1. 5.1.1 Personal-use Self-monitoring Blood Glucose Devices (Value and Volume, 2012 - 2024)

    2. 5.2 By Component

      1. 5.2.1 Glucometer Devices

      2. 5.2.2 Test Strips

      3. 5.2.3 Lancets

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States (Value and Volume, 2012 - 2024)

          1. 5.3.1.1.1 By Device (Glucometer Device, Test Strips, Lancets)

        2. 5.3.1.2 Canada (Value and Volume, 2012 - 2024)

          1. 5.3.1.2.1 By Device (Glucometer Device, Test Strips, Lancets)

        3. 5.3.1.3 Rest of North America (Value and Volume, 2012 - 2024)

          1. 5.3.1.3.1 By Device (Glucometer Device, Test Strips, Lancets)

      2. 5.3.2 Europe

        1. 5.3.2.1 France (Value and Volume, 2012 - 2024)

          1. 5.3.2.1.1 By Device (Glucometer Device, Test Strips, Lancets)

        2. 5.3.2.2 Germany (Value and Volume, 2012 - 2024)

          1. 5.3.2.2.1 By Device (Glucometer Device, Test Strips, Lancets)

        3. 5.3.2.3 Italy (Value and Volume, 2012 - 2024)

          1. 5.3.2.3.1 By Device (Glucometer Device, Test Strips, Lancets)

        4. 5.3.2.4 Spain (Value and Volume, 2012 - 2024)

          1. 5.3.2.4.1 By Device (Glucometer Device, Test Strips, Lancets)

        5. 5.3.2.5 United Kingdom (Value and Volume, 2012 - 2024)

          1. 5.3.2.5.1 By Device (Glucometer Device, Test Strips, Lancets)

        6. 5.3.2.6 Russia (Value and Volume, 2012 - 2024)

          1. 5.3.2.6.1 By Device (Glucometer Device, Test Strips, Lancets)

        7. 5.3.2.7 Rest of Europe (Value and Volume, 2012 - 2024)

          1. 5.3.2.7.1 By Device (Glucometer Device, Test Strips, Lancets)

      3. 5.3.3 Latin America

        1. 5.3.3.1 Mexico (Value and Volume, 2012 - 2024)

          1. 5.3.3.1.1 By Device (Glucometer Device, Test Strips, Lancets)

        2. 5.3.3.2 Brazil (Value and Volume, 2012 - 2024)

          1. 5.3.3.2.1 By Device (Glucometer Device, Test Strips, Lancets)

        3. 5.3.3.3 Rest of Latin America (Value and Volume, 2012 - 2024)

          1. 5.3.3.3.1 By Device (Glucometer Device, Test Strips, Lancets)

      4. 5.3.4 Asia-Pacific

        1. 5.3.4.1 Japan (Value and Volume, 2012 - 2024)

          1. 5.3.4.1.1 By Device (Glucometer Device, Test Strips, Lancets)

        2. 5.3.4.2 South Korea (Value and Volume, 2012 - 2024)

          1. 5.3.4.2.1 By Device (Glucometer Device, Test Strips, Lancets)

        3. 5.3.4.3 China (Value and Volume, 2012 - 2024)

          1. 5.3.4.3.1 By Device (Glucometer Device, Test Strips, Lancets)

          2. 5.3.4.3.2 By End User (Hospital and Home)

        4. 5.3.4.4 India (Value and Volume, 2012 - 2024)

          1. 5.3.4.4.1 By Device (Glucometer Device, Test Strips, Lancets)

          2. 5.3.4.4.2 By End User (Hospital and Home)

        5. 5.3.4.5 Australia (Value and Volume, 2012 - 2024)

          1. 5.3.4.5.1 By Device (Glucometer Device, Test Strips, Lancets)

        6. 5.3.4.6 Vietnam (Value and Volume, 2012 - 2024)

          1. 5.3.4.6.1 By Device (Glucometer Device, Test Strips, Lancets)

        7. 5.3.4.7 Malaysia (Value and Volume, 2012 - 2024)

          1. 5.3.4.7.1 By Device (Glucometer Device, Test Strips, Lancets)

        8. 5.3.4.8 Indonesia (Value and Volume, 2012 - 2024)

          1. 5.3.4.8.1 By Device (Glucometer Device, Test Strips, Lancets)

        9. 5.3.4.9 Philippines (Value and Volume, 2012 - 2024)

          1. 5.3.4.9.1 By Device (Glucometer Device, Test Strips, Lancets)

        10. 5.3.4.10 Thailand (Value and Volume, 2012 - 2024)

        11. 5.3.4.11 Rest of Asia-Pacific (Value and Volume, 2012 - 2024)

          1. 5.3.4.11.1 By Device (Glucometer Device, Test Strips, Lancets)

      5. 5.3.5 Middle East & Africa

        1. 5.3.5.1 Saudi Arabia (Value and Volume, 2012 - 2024)

          1. 5.3.5.1.1 By Device (Glucometer Device, Test Strips, Lancets)

          2. 5.3.5.1.2 By End User (Hospital and Home)

        2. 5.3.5.2 Iran (Value and Volume, 2012 - 2024)

          1. 5.3.5.2.1 By Device (Glucometer Device, Test Strips, Lancets)

        3. 5.3.5.3 Egypt (Value and Volume, 2012 - 2024)

          1. 5.3.5.3.1 By Device (Glucometer Device, Test Strips, Lancets)

        4. 5.3.5.4 Oman (Value and Volume, 2012 - 2024)

          1. 5.3.5.4.1 By Device (Glucometer Device, Test Strips, Lancets)

        5. 5.3.5.5 South Africa (Value and Volume, 2012 - 2024)

          1. 5.3.5.5.1 By Device (Glucometer Device, Test Strips, Lancets)

        6. 5.3.5.6 Rest of Middle & Africa (Value and Volume, 2012 - 2024)

          1. 5.3.5.6.1 By Device (Glucometer Device, Test Strips, Lancets)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2012-2024)

    2. 6.2 Type-2 Diabetes Population (2012-2024)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 Roche

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Arkray

      5. 7.1.5 Ascensia Diabetes Care

      6. 7.1.6 Agamatrix Inc.

      7. 7.1.7 Bionime Corporation

      8. 7.1.8 Acon

      9. 7.1.9 Trivida

      10. 7.1.10 Rossmax

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Personal-use Self-monitoring Blood Glucose Market market is studied from 2018 - 2026.

The Personal-use Self-monitoring Blood Glucose Market is growing at a CAGR of 0% over the next 5 years.

North America is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Roche, Abbott, Ascensia, Life scan are the major companies operating in Personal-use Self-monitoring Blood Glucose Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!